Report Highlights
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Report Includes
- 30 data tables and 20 additional tables
- A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
- Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
- Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
- Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
- Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
- Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
- Detailed company profiles of the leading industry players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Healthcare, Merck KGaA, PerkinElmer and Thermo Fisher Scientific Inc.
Report Scope
This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. These are biospecimen preparation techniques, cell separation products, and cell and tissue characterization products. These categories are further subdivided into various types. The report also covers the market for cell and tissue analysis products by end user. The end users of cell and tissue analysis products are categorized as research and academics, biopharmaceuticals, and healthcare and clinical. Excluded from this report are immunoassays.
BCC Research analyzed each market and its application, regulatory environment, new products and advancements, patent analysis, market projections, and market shares. The current report provides a detailed analysis of the market’s drivers, challenges, opportunities, and impact of COVID-19. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||||
| Base year market size | $16.7 billion | ||||||||||||||||||||||||
| Market size forecast | $28.9 billion | ||||||||||||||||||||||||
| Growth rate | CAGR of 9.6% for the forecast period of 2022-2027 | ||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||
| Segments covered | technology type, end-user, and region | ||||||||||||||||||||||||
| Regions covered | North America, Europe, Emerging markets | ||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global cell and tissue analysis products market reached $10.8 billion in 2015 and should reach nearly $12.5 billion by 2020, with a compound annual growth rate (CAGR) of 2.8% through 2020.
Report Includes
- An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
- Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
- Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
- Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Report Highlights
The global cell and tissue analysis market was valued at $6.9 billion in 2011 and should reach $7.1 billion in 2012. Total market value is expected to reach $9.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.2%.
Report Includes
- An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
- Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
- Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
- Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Report Highlights
- Overall sales in the global market of cell and tissue analysis products were worth $2.6 billion in 2008, which increased to an estimated $2.8 billion in 2009. By 2014, it is projected to increase to $4.5 billion, for a 5-year CAGR of 10.1%.
- The largest segment of the market, cell and tissue characterization products was valued at $1.2 billion in 2008; this is expected to increase to $1.3 billion in 2009, and is projected to reach $2.2 billion in 2014, for a 5-year CAGR of 10.8%.
- Sales in the cell separation products segment amounted to $1.2 billion in 2008, increased to an estimated $1.3 billion in 2009, and is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 9.8%.
Related Reports
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
Global Markets for Orphan Drugs
The global market for orphan drugs is expected to increase from $233.9 billion in 2023 to $415.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.2% during the forecast period of 2023-2028.
Microbial Products: Technologies, Applications and Global Markets
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More